Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers
HJ Weiss, D Meyer, R Rabinowitz, G Pietu, JP Girma, WJ Vicic, and J Rogers
Four members (from four generations) of a family with a mild bleeding disorder and intermittent thrombocytopenia had decreased plasma levels of properties related to factor VIII/von Willebrand factor (FVIII/VWF), an absence of high-molecular-weight forms of FVIII/VWF in the plasma (but normal multimeric structure in the platelets), and increased ristocetin-induced platelet aggregation, as in Type IIB von Willebrand's disease. However, unlike the abnormality in FVIII/VWF in Type IIB disease, the basic defect in this family was in their platelets, which absorbed FVIII/VWF high-molecular-weight multimers at lower concentrations of ristocetin than did normal platelets. In addition, either in platelet-rich plasma or suspended in buffer, their platelets were aggregated by unmodified normal human FVIII/VWF without ristocetin. Since the abnormalities of plasma FVIII/VWF in this family may be secondary to the platelet abnormalities, the term "pseudo-von Willbrand's disease" may be suitably descriptive of their disorder.
This article has been cited by other articles:
Arya, M., Kolomeisky, A. B., Romo, G. M., Cruz, M. A., Lopez, J. A., Anvari, B.
(2005). Dynamic Force Spectroscopy of Glycoprotein Ib-IX and von Willebrand Factor. Biophys. J
88: 4391-4401
[Abstract][Full Text]
Othman, M., Notley, C., Lavender, F. L., White, H., Byrne, C. D., Lillicrap, D., O'Shaughnessy, D. F.
(2005). Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. Blood
105: 4330-4336
[Abstract][Full Text]
Nishio, K., Anderson, P. J., Zheng, X. L., Sadler, J. E.
(2004). Binding of platelet glycoprotein Ib{alpha} to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. Proc. Natl. Acad. Sci. USA
101: 10578-10583
[Abstract][Full Text]
Dumas, J. J., Kumar, R., McDonagh, T., Sullivan, F., Stahl, M. L., Somers, W. S., Mosyak, L.
(2004). Crystal Structure of the Wild-type von Willebrand Factor A1-Glycoprotein Ib{alpha} Complex Reveals Conformation Differences with a Complex Bearing von Willebrand Disease Mutations. J. Biol. Chem.
279: 23327-23334
[Abstract][Full Text]
Marchese, P., Saldivar, E., Ware, J., Ruggeri, Z. M.
(1999). Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field. Proc. Natl. Acad. Sci. USA
96: 7837-7842
[Abstract][Full Text]
Lopez, J. A., Andrews, R. K., Afshar-Kharghan, V., Berndt, M. C.
(1998). Bernard-Soulier Syndrome. Blood
91: 4397-4418
[Full Text]
Moriki, T., Murata, M., Kitaguchi, T., Anbo, H., Handa, M., Watanabe, K., Takahashi, H., Ikeda, Y.
(1997). Expression and Functional Characterization of an Abnormal Platelet Membrane Glycoprotein Ibalpha (Met239 right-arrow Val) Reported in Patients With Platelet-Type von Willebrand Disease. Blood
90: 698-705
[Abstract][Full Text]
Dong, J.-f., Schade, A. J., Romo, G. M., Andrews, R. K., Gao, S., McIntire, L. V., Lopez, J. A.
(2000). Novel Gain-of-function Mutations of Platelet Glycoprotein Ibalpha by Valine Mutagenesis in the Cys209-Cys248 Disulfide Loop. FUNCTIONAL ANALYSIS UNDER STATIC AND DYNAMIC CONDITIONS. J. Biol. Chem.
275: 27663-27670
[Abstract][Full Text]